Xconomy’s Digital Events →
December 3, 2020 · New York
Sarah Karlin-Smith covers regulation of the pharmaceutical industry for the Pink Sheet.
It will be difficult to compare Moderna, Inc. and Pfizer Inc.’s coronavirus vaccines based on their Phase 3 study designs, some vaccines experts said.
“Both trials appeared to be well designed,”... Read more »
Fast enrollment of the right patient populations will be critical to quickly conducting Phase III trials of COVID-19 vaccines and this will likely mean taking concerted steps to reach out to... Read more »
The US Health and Human Services agency isn’t ready to go all in on “pull” incentives to encourage the development of new antibiotics, the agency indicated in response to a new... Read more »
Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.